Clinical Trials Browser

Phase 2 × Carcinoma, Renal Cell × nintedanib × Clear all

NCT01024920 2021-07-19

Compare Safety and Efficacy of BIBF 1120 Versus Sunitinib.

Phase 2 Completed

99 enrolled 45 charts

Carcinoma, Renal Cell